I said this stock was going down because of the issue of PML. More and more doctors are telling their MS patients to go off Tysabri becaUse of the risk. I will say it again this stock will be under $100.00 by the end of the year.
The issue of PML has been known for over 10 years now, even since Elan used to get slammed by it. SCornelius49, are you saying the problem is getting worse? Please present some facts.
The facts are the longer patients are on Tysabri the chances of developing PML are higher. Read the Tysabri label.
You keep saying it and you keep being wrong. You are letting your emotions get in the way of facts.
Do you MS? Have you ever been on Tysabri? I have MS and have been on Tysabri. So lets talk about emotions
And on May 8th you said that BIIB stock would be at $130 by August. You were wrong about that as well.
This stock as dropped $31.39 a share since the first of the year. Dropped $20.42 the last month and dropped $31.39 in the last 3 months. Those are the facts.
there is special test since 2 years ago and positives on that one are not recommended tysabri.there are less than 10 % of those .tysabri by far is the best ms medication.do not spread bs .
You are wrong it is 50% that test positive for the JC virus not 10%
Yes, perhaps...and they're going on Tecfidera, another BIIB, safer drug.